To place an order you must be registered with HeartGenetics. If you already completed your registration, login here. Otherwise, click the button above to request a registration.
Your account is waiting for validation. After validation completed you will be able to start your purchase order.

Warfarin PGX Kit | 2016

Genetic Study of Warfarin Pharmacogenetics

REF: 5046

Fully Optimised and integrated with the iPLEX® MassARRAY® system, from logo-agena

The Warfarin PGX Kit | 2016 is a qualitative in vitro diagnostic device (IVD) for genotyping a panel of 3 genetic variants, in human genomic DNA samples, and estimating the therapeutic warfarin dose to achieve an INR* of 2–3 .

Genetic Kits contain ready-to-use and fully optimised amplification and extension primer mixes, and an external control.

The genetic panel of the Warfarin PGX Kit |2016 comprises genetic variants that affect patient’s metabolizer phenotype (CYP2C9) and sensitivity to warfarin (VKORC1).

*International Normalised Ratio

Back to Product List

Number of genetic variants: 3

Genes (description):
CYP2C9 | Cytochrome P450 family 2 subfamily C member 9
VKORC1 |Vitamin K epoxide reductase complex subunit 1

External control: Artificial DNA templates

Contains sufficient for: 30 tests

Shipping conditions: Room temperature

Storage: All components should be stored at -20°C upon receipt for optimum stability. Repeated freeze/thaw cycles should be avoided.


  • Customer and sample information
  • Genotyping summary table
  • Gene function and associated genetic risk
  • Phenotype/clinical profile association
  • Frequency of the genetic variant
  • Pharmacogenetics
  • Methods and analytical section
  • Trustful scientific references
  • Gene panel analysed
  • Your company information and details

European Society of Human Genetics.

Genetic reports follow all recommendations from the European Society of Human Genetics

Please get in contact with

Please get in contact with